Navigation Links
Researchers discover promising prognostic marker for aggressive breast cancer
Date:1/23/2013

stage breast cancer patients will have disease progression," adds Dr. Narla. "More studies need to be done, but this could provide an important prognostic marker to determine which patients need to be treated more aggressively or watched more closely."

Dr. Narla came to UH Case Medical Center and Case Western Reserve in spring, 2012, from Mt. Sinai and is the first Harrington Distinguished Scholar (Early Career Award). This inaugural award provides physician-scientists with the ability to tap into grant funding and a peer network of innovators and mentors within the infrastructure of the Harrington Discovery Institute at UH Case Medical Center. The Institute is part of the $250 million Harrington Project for Discovery & Development, which was launched in February, 2012, with a $50 million gift to UH from the Harrington family of Hudson, OH.

Dr. Narla's laboratory focuses on the identification and characterization of the genes and pathways involved in cancer metastasis. By studying the functional role of the KLF6 tumor suppressor gene, Dr. Narla and his team have identified new signaling pathways regulated by this gene family thus providing new insight into cancer diagnosis and treatment. The team's research found that KLF6 and FOXO1, both tumor suppressor genes, are turned off as cancer spreads through the body. Since first discovering the KLF6 gene 13 years ago as a medical student at Mount Sinai School of Medicine in the laboratory of Dr. Scott Friedman, Dr. Narla has been involved in the identification and characterization of the gene and its role in cancer development.

"In this new research as well as previous studies, Goutham and his team have uncovered important and previously unrecognized genetic markers in cancer," said Stanton Gerson, MD, Director of the Case Comprehensive Cancer Center and the UH Case Medical Center Seidman Cancer Center. "This work highlights how understanding the basic mechanisms regulating cancer development and pro
'/>"/>

Contact: Alicia Reale
alicia.reale@uhhospitals.org
University Hospitals Case Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Researchers design a new imaging technique for identifying the age and sex of a corpse
2. Researchers map emotional intelligence in the brain
3. Researchers find that simple blood test can help identify trauma patients at greatest risk of death
4. Mayo Clinic researchers identify enzyme involved in deadly brain tumors
5. UNC researchers use luminescent mice to track cancer and aging in real-time
6. Gothenburg researchers make world top 10
7. Autism Researchers Surprised by Impaired Brain Connections
8. Researchers identify ways to improve quality of care measurement from electronic health records
9. Researchers identify genetic mutation for rare cancer
10. Researchers Link 25 New Gene Variants to Autism
11. Fox Chase researchers discover novel role of the NEDD9 gene in early stages of breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... (PRWEB) March 03, 2015 Dan E. Chambers, ... a special focus on capital crimes, recently spoke on the ... murder trial. The hosts of the Independent Journal Review radio ... history working first as a prosecutor and now as a ... the decisions made in the trial and sentencing of this ...
(Date:3/3/2015)... Dallas, TX (PRWEB) March 04, 2015 ... comprehensive information on the therapeutic development for Alopecia. Alopecia ... alopecia are the two main types of alopecia. Causes ... autoimmune disorder. Symptoms of alopecia may include male pattern ... and broken hair. Alopecia can be classified as focal ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The first ... the National Sleep Foundation. The event brings recognition to ... over. , According to the Centers for ... problems of one form or another. Too little or ... risk of physical illness and depression, and even a ...
(Date:3/3/2015)... OH (PRWEB) March 03, 2015 ... to better predict antidepressant treatment outcomes for patients ... resources, than any of the individual genes that ... by investigators from the Mayo Clinic and Assurex ... i. , The proprietary technology of the ...
(Date:3/3/2015)... The North America application delivery ... $1,224.6 million to $1,694.6 million, at a ... , Browse through the TOC of North ... analysis of industry trends and segments, with ... http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html , An application delivery ...
Breaking Medicine News(10 mins):Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Alopecia Therapeutics Drugs and Companies Pipeline Market H1 2015 Review Report Available at RnRMarketResearch.com 4Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3
... In a study that seems to pivot on a paradox, ... stimulant as an immune system suppressor to treat a common, ... cancer patients. The effect, in some cases, was profound. ... issue of the New England Journal of Medicine , ...
... Maureen Salamon HealthDay Reporter , WEDNESDAY, Nov. 30 ... with women and men facing different heart risks even when ... study suggests. Analyzing the results of coronary CT angiographies ... in 480 patients with acute chest pain, scientists from the ...
... ARBOR, Mich. As cancer researchers continue to ... are also creating a catalog of possible targets ... Michigan Comprehensive Cancer Center and Michigan Center for ... aimed at solving the practical challenges involved in ...
... that an inflammatory mechanism known as inflammasome may lead ... as a heart attack, pointing researchers toward developing more ... Following a heart attack, an inflammatory process occurs in ... nutrients. This process helps the heart to heal, but ...
... News) -- Toddlers who take anti-HIV drugs have higher cholesterol ... study shows. It,s the first such finding in toddlers ... National Institutes of Health researchers and colleagues. They reviewed ... to HIV in the womb. Of the 83 who were ...
... led by the University of Kentucky researcher Elaine Wittenberg-Lyles ... themselves and require their own unique care needs. ... Qualitative Health Research , assessed the individual stressors that ... and the intervention team. The caregivers were asked to ...
Cached Medicine News:Health News:New approach to graft-versus-host treatment results in improvement for some patients 2Health News:New approach to graft-versus-host treatment results in improvement for some patients 3Health News:New approach to graft-versus-host treatment results in improvement for some patients 4Health News:Clogged Arteries Pose Different Dangers for Men, Women: Study 2Health News:Clogged Arteries Pose Different Dangers for Men, Women: Study 3Health News:Genetic sequencing could help match patients with biomarker-driven cancer trials, treatments 2Health News:Genetic sequencing could help match patients with biomarker-driven cancer trials, treatments 3Health News:Researchers examine role of inflammatory mechanisms in a healing heart 2Health News:Toddlers Taking HIV Drugs Have Higher Cholesterol 2Health News:Study shows hospice caregivers need routine care interventions 2
(Date:3/3/2015)... /CNW/ - The issue: Health ... injected at Art Nails Ltd., located at 751 Helmcken St., ... it contained no labelling. All products administered by injection in ... must have approved labelling. The store owner ... Potential risks associated with injecting an unauthorized version of a health ...
(Date:3/3/2015)...  American Biosurgical, LLC ("ABI") ( www.americanbiosurgical.com ) ... engaged in the design, development and production of ... medical device companies has announced the acquisition of ... medical cable manufacturer based in North Carolina.  The ... the name MTI Medical Cables.  ...
(Date:3/3/2015)... Mass. , March 3, 2015  Web ... and manufacturing services in the Medical Device, Advanced ... has been named a 3M Medical Specialties Preferred ... new status will allow companies to streamline their ... point of contact for 3M materials, intermediate converting ...
Breaking Medicine Technology:Advisory - Health product seized from Art Nails in Vancouver 2American Biosurgical Acquires MTI Corporation 2Web Industries Receives 3M Preferred Converter Status 2
...   Seminars: February 14-15, 2012 ,Exhibition: February ... largest packaging tradeshow, announced the launch of two new ... 14-16, 2012. The seminars focus on sustainability and automation ... impacting all sectors of the packaging industry. ...
... Inc. (OTC: PLCSF), a company focused on innovative medical ... patient in the CIN-RG trial, the company,s pivotal trial ... RenalGuard System™ in the prevention of Contrast-Induced Nephropathy (CIN).  ... secure regulatory approval by the U.S. Food and Drug ...
Cached Medicine Technology:WestPack Launches New Sustainability and Automation and Cost Control Seminars 2First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 2First Patient Treated in PLC Systems' RenalGuard® U.S. Pivotal Trial 3
Latex agglutination slide test for the qualitative and quantitative detection of rubella virus antibody in serum....
A Color-Enhanced Slide Agglutination Test for the Rapid Qualitative and Semi-Quantitative Detection of Rheumatoid Factor in Serum....
Color-enhanced hemagglutination slide test for the rapid qualitative and semi-quantitative detection of infectious mononucleosis heterophile antibodies in serum or plasma....
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
Medicine Products: